纳米技术方法缓解生物免疫性:文学综述
Jouri Alanazi1, Fadilah Sfouq Aleanizy2, Fulwah Yahya Alqahtani2
1Drug Sector, Saudi FDA, Riyadh 13513, Saudi Arabia.
Pharmaceutics
|July 30, 2025
概括
像单克隆抗体 (mAbs) 这样的生物疗法可以引起抗药抗体 (ADA),降低有效性和安全性. 纳米技术提供了有希望的策略,以尽量减少这些免疫反应,改善患者的结果.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 纳米技术 纳米技术
背景情况:
- 生物疗法,特别是单克隆抗体 (mAbs),已经改变了医学.
- 免疫性,即诱导抗药抗体 (ADA),经常限制它们的临床成功.
- ADAs可以降低药物的疗效,改变药理动力学,并引起不良事件.
研究的目的:
- 对抗生物药物的ADA形成机制的审查.
- 探索基于纳米技术的降低免疫性策略.
- 提高生物制剂的治疗潜力和安全性.
主要方法:
- 对生物免疫性现有文献的审查.
- 对生物药物的免疫系统识别途径的分析.
- 研究各种纳米技术应用用于ADA缓解.
主要成果:
- 了解ADA的形成对于管理生物疗法至关重要.
- 纳米技术提供了各种方法来控制对生物制剂的免疫反应.
- 这些策略有可能提高药物疗效和患者安全.
结论:
- 解决免疫性是最大化生物疗法益处的关键.
- 纳米技术为克服ADA挑战提供了创新的解决方案.
- 进一步研究基于纳米技术的免疫调节可以促进生物药物开发.
关键词:
抗药抗体 (ADA) 是一种抗药性抗体.脂质纳米粒子 (LNP) 是一种单克隆抗体 (mAbs) 是一种单克隆抗体.合成疫苗颗粒 (SVP) 是一种耐受性纳米颗粒的耐受性纳米颗粒基聚 (基基) 纳米子更多相关视频
08:27Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
Published on: August 13, 2021
4.7K
11:07Whole-animal Imaging and Flow Cytometric Techniques for Analysis of Antigen-specific CD8+ T Cell Responses after Nanoparticle Vaccination
Published on: April 29, 2015
13.3K
相关概念视频
Microorganisms in Medicine and Therapeutics
345
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
345
Hybridoma Technology
15.3K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
15.3K
